NHS Supply Chain purchases Elekta equipment for GBP 19 million
UK cancer patients to benefit from sophisticated radiation treatment devices and software
CRAWLEY, England, April 4 – In a deal worth GBP 19 million, NHS Supply Chain has agreed to purchase several Elekta Synergy® linear accelerators with Agility™ multileaf collimators as well as X-ray Volume Imaging (XVI) systems and licenses to connect to Elekta’s MOSAIQ® oncology information system.
Both Elekta Synergy and Agility offer advanced radiotherapy techniques that enable high precision treatment in managing a range of cancers. MOSAIQ creates an efficient clinical environment from diagnosis to treatment, giving clinicians more time to focus on patients.
Andrew Brown, Managing Director of Capital Solutions within NHS Supply Chain, says: “By purchasing a range of cancer treatment solutions from Elekta, we expect to deliver high clinical value to several National Health Service (NHS) health care organizations and hospitals – as responsibly, cost-effectively and sustainably as possible.
“This deal with Elekta reflects our commitment to ensuring that patients receive the most efficient and latest treatment delivery techniques.”
Ian Alexander, Executive Vice President Region Europe, Africa, Latin America and Middle East at Elekta, says: “Getting the right treatment option for patients with cancer means better outcomes and fewer side effects. That’s why we have worked closely with the NHS for more than 20 years.”
The deal was booked during Elekta’s fourth quarter of its fiscal year.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 16:30 CET on April 4, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.
About NHS Supply Chain
NHS Supply Chain is operated by DHL as Agent of the NHS Business Services Authority. It manages the sourcing, delivery and supply of health care products and food for over 1,000 NHS trusts and health care organizations.
The organization was formed in 2006 from the NHS Logistics Authority and parts of the NHS Purchasing and Supply Agency (NHS PASA).
Tags: